Skip to main content

Accidental Ixazomib Overdose in a Patient With Multiple Myeloma - PubMed

Accidental Ixazomib Overdose in a Patient With Multiple Myeloma - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/33980053/

Multiple myeloma is the second most common hematological malignancy. Ixazomib is the first oral proteasome inhibitor approved in the United States for the management of multiple myeloma who have received at least one prior treatment. The availability of oral chemotherapeutic agents for the managemen ...

  • 4 weeks
    Valuable piece as our best intended instructions don’t always “reach” the patient and while hopefully uncommon, this can be a resource for a practicing clinician
  • 4 weeks
    Please share your thoughts concerning overdose on oral chemotherapy.